Pharmaceutical composition for relieving cancer-related fatigue and chronic fatigue syndrome as well as preparation method and application of pharmaceutical composition

Abstract

The invention provides a pharmaceutical composition for relieving cancer-related fatigue and chronic fatigue syndrome. The pharmaceutical composition is prepared from the following raw material medicines in parts by weight: 8-12 parts of sea-buckthorn, 8-12 parts of hovenia dulcis thunb, 8-12 parts of rhizoma polygonati, 8-12 parts of Chinese dates, 8-12 parts of raspberries, 8-12 parts of mulberries, 8-12 parts of poria cocos, 8-12 parts of coix seeds, 2.4-3.6 parts of ginseng and 4-6 parts of roses. The invention further discloses a preparation method and application of the pharmaceutical composition. The pharmaceutical composition provided by the invention is precise and appropriate in formula, can reinforce qi and nourish blood, strengthen spleen and eliminate phlegm, tonify middle warmer and purge, conforms to the pathology of fatigue, qi and blood deficiency and phlegm stasis, effectively relieves fatigue, laziness to speak, inappetence, heavy head and limb fatigue, palpitation and insomnia of tumor and chronic fatigue patients, provides a new drug choice for clinic, and has high practical application value.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for relieving cancer-related fatigue and chronic fatigue syndrome, a preparation method and application. Background technique [0002] Cancer-related fatigue (CRF), also known as cancer-related fatigue, is a distressing, persistent, subjective feeling of physical, emotional, and / or cognitive fatigue or exhaustion that is out of proportion to recent activities, Related to cancer or cancer treatment, with functional impairment (NCCN definition). There are 3.4454 million new cases of CRF every year, and it is commonly found in cancer patients. The tenth revision of the International Classification of Diseases Conference (ICD-10) described the symptoms of CRF as nonspecific weakness, fatigue, weakness, general weakness, heaviness of limbs, slowness of movement, lethargy, insomnia, inability to concentrate, irritability, and tendency to mourn ...

AI Technical Summary

Problems solved by technology

However, there are still some deficiencies in the current research on CFS: so far there is no large-scale and large-scale investigation and analysis of the epidemiology of CFS in China; the etiology and pathogenesis of CFS have not yet been clearly studied; Selenium, vitamin A, vitamin C, and vitamin E, etc., psychotherapy and traditional Chinese medicine treatment, lack of a unified clinical program for the treatment of CFS and the prevention of high-risk groups

[0006] At present, there are a large number of patients with cancer-related fatigue and chronic fatigue syndrome, and there are no targeted clinical products for the treatment of cancer-related fatigue and chronic fatigue syndrome, and no unified and effective treatment plan has been formed. affected the patient's quality of life

Images